Heart attack care dangerously unequal for women: Study
Fewer women who suffer a heart attack would die if they were given the same treatments as men, a new study found.
Researchers analyzed the outcomes of 180,368 Swedish patients who suffered a heart attack over a 10-year period, BBC reported.
They found women were three times more likely to die than men in the year after having a heart attack.
The British Heart Foundation said, “Heart attacks are often seen as a male health issue, but more women die from heart disease than breast cancer.”
Researchers at the University of Leeds and the Karolinska Institute in Sweden analyzed data from Sweden’s online cardiac registry.
They found women were on average less likely than men to receive the recommended treatments after a heart attack.
Professor Chris Gale, of the University of Leeds, who coauthored the study, said: “This is because there’s misconception amongst the general public and healthcare professionals about what heart attack patients are like.
“Typically, when we think of a heart attack patient, we see a middle-aged man who is overweight, has diabetes and smokes.
“This is not always the case; heart attacks affect the wider spectrum of the population — including women.”
Gender differences
In one speci¿c heart condition, women were 34 percent less likely to receive procedures which clear blocked arteries, such as bypass surgery and stents.
They were also 24 percent less likely to be prescribed statin medication, which helps to prevent a second heart attack, and 16 percent less likely to be given aspirin, which helps to prevent blood clots.
This is despite guidelines suggesting all three treatments should be given to both genders.
The study found that when women did receive all the recommended treatments, the gap in mortality between the sexes decreased in almost all circumstances.
Roughly 124,000 men and 70,000 women are hospitalized for heart attacks in the UK per year. Gale said that from their very ¿rst point of contact with healthcare professionals, women are less likely to receive the same diagnostic tests, leading them to be 50 percent more likely to be initially misdiagnosed.
“That then feeds the whole pathway of care. If you missed the ¿rst, earliest opportunity for care — you’re much more likely to miss the next point of contact — and it all adds up cumulatively and leads to a greater mortality.”